larotrectinib
bayer
['larotrectinib', 'sclc', 'lung', 'thanks', 'nsclc']
#asco22, thanks for the great presentation on updated efficacy and safety results with #larotrectinib in #trk+ fusion lung cancer.
thanks all speakers in #nsclc: testing is the key to find these lung patients who can benefit from efficient treatment.
#ntrk #meded 
group of independent and international experts in the field of medical #oncology and #pathology related to #NTRK gene fusions. Part of https://t.co/83nVzqjBga